tiprankstipranks
Trending News
More News >
Tenax Therapeutics (TENX)
NASDAQ:TENX
US Market

Tenax Therapeutics (TENX) Income Statement

Compare
602 Followers

Tenax Therapeutics Income Statement

Last quarter (Q3 2025), Tenax Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Tenax Therapeutics's net income was $-15.80M. See Tenax Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ -114.75K
Operating Expenses
$ 19.49M$ 8.23M$ 11.05M$ 32.73M$ 9.75M
Depreciation and Amortization
$ 0.00$ 8.00K$ 113.33K$ 108.98K$ 114.75K
EBITDA
$ -17.58M$ -7.68M$ -10.93M$ -32.36M$ -9.74M
Operating Income
$ -19.49M$ -8.23M$ -11.05M$ -32.73M$ -9.87M
Other Income/Expenses
$ 1.89M$ 523.00K$ 4.75K$ 253.88K$ 16.54K
Pretax Income
$ -17.60M$ -7.71M$ -11.05M$ -32.47M$ -9.85M
Net Income
$ -17.60M$ -7.71M$ -11.05M$ -32.47M$ -9.85M
Per Share Metrics
Basic EPS
$ -1.15$ -31.09$ -600.80$ -2.52K$ -2.13K
Diluted EPS
$ -1.15$ -31.04$ -600.80$ -2.52K$ -2.13K
Weighted Average Shares Outstanding
15.27M 248.00K 18.39K 12.86K 4.63K
Weighted Average Shares Outstanding (Diluted)
15.27M 248.45K 18.39K 12.86K 4.63K
Currency in USD

Tenax Therapeutics Earnings and Revenue History